![Keith Brownlie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Brownlie
Director/Board Member at
CELLDEX THERAPEUTICS, INC.
Net worth: 25 348 $ as of 2026-07-30
Profile
Mr. Keith L.
Brownlie, CPA, is an Independent Director at Celldex Therapeutics, Inc. and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Celldex Therapeutics, Inc. and Trek Therapeutics PBC.
Mr. Brownlie was previously employed as an Independent Director by Phio Pharmaceuticals Corp., an Independent Director by EpiCept Corp., an Independent Director by Soligenix, Inc., an Audit Partner by Ernst & Young LLP, and a Vice President & Trustee by New Jersey Society of Certified Public Accountants.
He also served on the board at Cancer Genetics, Inc. He received his undergraduate degree from Lehigh University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-24 | 666 ( 0% ) | 25 348 $ | 2026-07-30 |
Keith Brownlie active positions
| Companies | Position | Start |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Director/Board Member | 2017-06-14 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Director/Board Member | - |
Former positions of Keith Brownlie
| Companies | Position | End |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Director/Board Member | 2019-10-09 |
| SOLIGENIX, INC. | Director/Board Member | 2019-09-05 |
| CANCER GENETICS, INC. | Director/Board Member | 2014-12-07 |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Director/Board Member | 2013-08-20 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 2009-12-31 |
Training of Keith Brownlie
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Soligenix, Inc.
 Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Provides cancer diagnostics and clinical services | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
New Jersey Society of Certified Public Accountants
 New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Phio Pharmaceuticals Corp.
 Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Health Technology |
- Stock Market
- Insiders
- Keith Brownlie
